Explore more publications!
Technology Digest Bermuda
Got News to Share?

Technology Digest Bermuda: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Digest Bermuda.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on February 19, 2026

ROC Announces Pricing of Upsized Initial Public Offering
Feb. 19, 2026

ROC Announces Pricing of Upsized Initial Public Offering

Indeterminate GlobeNewswire
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026
Feb. 19, 2026

Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026

Indeterminate GlobeNewswire
Prospective Validation Study in JAAD Demonstrates Castle Biosciences’ AdvanceAD-Tx™ Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis
Feb. 19, 2026

Prospective Validation Study in JAAD Demonstrates Castle Biosciences’ AdvanceAD-Tx™ Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis

Indeterminate GlobeNewswire
VivoPower Announces Leadership Changes
Feb. 19, 2026

VivoPower Announces Leadership Changes

Indeterminate GlobeNewswire
Global Pharmaceutical Packaging Manufacturer Selects Kneat
Feb. 19, 2026

Global Pharmaceutical Packaging Manufacturer Selects Kneat

Indeterminate GlobeNewswire
AlphaTON Capital Releases Market Update on Outstanding Shares, Warrants, Options, and RSUs
Feb. 19, 2026

AlphaTON Capital Releases Market Update on Outstanding Shares, Warrants, Options, and RSUs

Indeterminate GlobeNewswire
Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
Feb. 19, 2026

Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen

Indeterminate GlobeNewswire
BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb. 19, 2026

BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

Indeterminate GlobeNewswire
Sniffer Robotics partners with Delmar Aerospace and Perspectum Drone Inspection Services, expanding into Canada and increasing U.S. West Coast presence
Feb. 19, 2026

Sniffer Robotics partners with Delmar Aerospace and Perspectum Drone Inspection Services, expanding into Canada and increasing U.S. West Coast presence

Indeterminate GlobeNewswire
iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results
Feb. 19, 2026

iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
Feb. 19, 2026

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

Indeterminate GlobeNewswire
Digital Realty Declares Quarterly Cash Dividends for Common and Preferred Stock
Feb. 19, 2026

Digital Realty Declares Quarterly Cash Dividends for Common and Preferred Stock

Indeterminate GlobeNewswire
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
Feb. 19, 2026

Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference

Indeterminate GlobeNewswire
CarGurus Announces Fourth Quarter and Full-Year 2025 Results
Feb. 19, 2026

CarGurus Announces Fourth Quarter and Full-Year 2025 Results

Indeterminate GlobeNewswire
Candel Therapeutics Announces Proposed $100 Million Public Offering
Feb. 19, 2026

Candel Therapeutics Announces Proposed $100 Million Public Offering

Indeterminate GlobeNewswire
Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Feb. 19, 2026

Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Galapagos verwelkomt Dr. Paulo Fontoura in haar Raad van Bestuur  
Feb. 19, 2026

Galapagos verwelkomt Dr. Paulo Fontoura in haar Raad van Bestuur  

Indeterminate GlobeNewswire
Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors  
Feb. 19, 2026

Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors  

Indeterminate GlobeNewswire
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Feb. 19, 2026

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Indeterminate GlobeNewswire
Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Feb. 19, 2026

Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions